瑶药足浴疗法联合正念冥想对慢性乙型病毒性肝炎肝郁脾虚型患者康复及睡眠质量的影响

Effect of Yao medicine foot bath therapy combined with mindfulness meditation on rehabilitation and sleep quality in chronic hepatitis B patients with liver stagnation and spleen deficiency syndrome

目的探讨瑶药足浴疗法联合正念冥想改善慢性乙型病毒性肝炎肝郁脾虚型患者睡眠质量及促进康复的效果。方法选取2022年1月—12月医院收治的慢性乙型病毒性肝炎肝郁脾虚型患者86例。根据治疗方式的不同对患者进行分组,对照组(n=43)实施常规治疗,观察组(n=43)在对照组基础上增加足浴疗法联合正念冥想治疗。采用焦虑自评量表(SAS)评估患者焦虑症状改善情况,采用匹兹堡睡眠质量指数量表(PSQI)评估患者睡眠质量,评价两组干预效果。结果治疗后,两组SAS评分均较治疗前下降,且观察组SAS评分低于对照组,差异有统计学意义(P<0.01)。治疗后,两组PSQI评分均较治疗前下降,且观察组PSQI评分低于对照组,差异有统计学意义(P<0.01)。观察组治疗总有效率97.67%(42/43),高于对照组的86.05%(37/43),差异有统计学意义(P<0.05)。结论瑶药足浴疗法联合正念冥想能有效改善慢性乙型病毒性肝炎肝郁脾虚型患者焦虑症状以及睡眠质量。

Objective To investigate the effect of Yao medicine foot bath therapy combined with mindfulness meditation on rehabilitation and sleep quality in chronic hepatitis B patients with liver stagnation and spleen deficiency syndrome.Methods A total of 86 patients were enrolled in this study,all of which were treated in the hospital from January 2022 to December 2022.The patients were divided into two groups according to the different treatment methods.The control group(n=43)was treated with routine treatment,and the observation group(n=43)was treated with foot bath therapy combined with mindfulness therapy on the basis of routine treatment.The Self-rating Anxiety Scale(SAS)score,Pittsburgh Sleep quality Index(PSQI)score and total effective rate were compared between two groups.Results The score of SAS was decreased in both two groups after treatment,and SAS score in the observation group was lower than that in the control group(P<0.01).The score of PSQI was decreased in both two groups after treatment,and PSQI score in the observation group was lower than that in the control group(P<0.01).The total effective rate of the observation group was higher than that of the control group(97.67%vs.86.05,P<0.05).Conclusion Yao medicine foot bath therapy combined with mindfulness meditation is potentially effective to improve the rehabilitation and sleep quality in chronic hepatitis B patients with liver stagnation and spleen deficiency syndrome.